Family · Pharmaceutical analytical standards
Tropisetron
A serotonin 5-HT3 receptor antagonist, patented in 1982 and approved for medical use in 1992: it is used mainly to prevent nausea and vomiting caused by chemotherapy. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Besides blocking 5-HT3 receptors it partially activates the alpha-7 nicotinic receptor, which is why it has also been studied for its effects on memory in animals.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
